These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 812927)

  • 61. Dietary vitamin D affects cell-mediated hypersensitivity but not resistance to experimental pulmonary tuberculosis in guinea pigs.
    Hernandez-Frontera E; McMurray DN
    Infect Immun; 1993 May; 61(5):2116-21. PubMed ID: 8478101
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Childhood BCG vaccination does not influence control of Mycobacterium tuberculosis growth by human bronchoalveolar lavage cells.
    Herzmann C; Sotgiu G; Schaberg T; Ernst M; Stenger S; Lange C;
    Tuberculosis (Edinb); 2015 May; 95(3):321-7. PubMed ID: 25794470
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
    Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
    Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mycobacterial infection in guinea pigs.
    Balasubramanian V; Wiegeshaus EH; Smith DW
    Immunobiology; 1994 Oct; 191(4-5):395-401. PubMed ID: 7713553
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mycobacterium tuberculosis sigE mutant ST28 used as a vaccine induces protective immunity in the guinea pig model.
    Troudt J; Creissen E; Izzo L; Bielefeldt-Ohmann H; Casonato S; Manganelli R; Izzo AA
    Tuberculosis (Edinb); 2017 Sep; 106():99-105. PubMed ID: 28802412
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Humanized NOG mice as a model for tuberculosis vaccine-induced immunity: a comparative analysis with the mouse and guinea pig models of tuberculosis.
    Grover A; Troy A; Rowe J; Troudt JM; Creissen E; McLean J; Banerjee P; Feuer G; Izzo AA
    Immunology; 2017 Sep; 152(1):150-162. PubMed ID: 28502122
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo.
    Pedroza-Roldán C; Guapillo C; Barrios-Payán J; Mata-Espinosa D; Aceves-Sánchez Mde J; Marquina-Castillo B; Hernández-Pando R; Flores-Valdez MA
    Vaccine; 2016 Sep; 34(40):4763-70. PubMed ID: 27546876
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Whole genome response in guinea pigs infected with the high virulence strain Mycobacterium tuberculosis TT372.
    Aiyaz M; Bipin C; Pantulwar V; Mugasimangalam R; Shanley CA; Ordway DJ; Orme IM
    Tuberculosis (Edinb); 2014 Dec; 94(6):606-15. PubMed ID: 25621360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
    Deng YH; He HY; Zhang BS
    J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Disease model: pulmonary tuberculosis.
    McMurray DN
    Trends Mol Med; 2001 Mar; 7(3):135-7. PubMed ID: 11286786
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pediatric tuberculosis in Alberta First Nations (1991-2000): outbreaks and the protective effect of bacille Calmette-Guérin (BCG) vaccine.
    Long R; Whittaker D; Russell K; Kunimoto D; Reid R; Fanning A; Nobert E; Melenka L; Yacoub W; Bhargava R
    Can J Public Health; 2004; 95(4):249-55. PubMed ID: 15362464
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The influence of dietary protein on the protective effect of BCG in guinea pigs.
    McMurray DN; Mintzer CL; Tetzlaff CL; Carlomagno MA
    Tubercle; 1986 Mar; 67(1):31-9. PubMed ID: 3715981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes.
    López B; Aguilar D; Orozco H; Burger M; Espitia C; Ritacco V; Barrera L; Kremer K; Hernandez-Pando R; Huygen K; van Soolingen D
    Clin Exp Immunol; 2003 Jul; 133(1):30-7. PubMed ID: 12823275
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations.
    Pooransingh S; Sakhamuri S
    Emerg Infect Dis; 2020 Mar; 26(3):624-625. PubMed ID: 31922950
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Macrophage activation and resistance to pulmonary tuberculosis.
    Lefford MJ
    Infect Immun; 1980 May; 28(2):508-15. PubMed ID: 6772560
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of diet and genetics on Mycobacterium bovis BCG vaccine efficacy in inbred guinea pigs.
    Cohen MK; Bartow RA; Mintzer CL; McMurray DN
    Infect Immun; 1987 Feb; 55(2):314-9. PubMed ID: 3804439
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Electron-capture gas chromatographic-chemical ionization mass spectrometric study of sera from people vaccinated with bacille Calmette-Guerin for characteristic metabolites.
    Syriopoulou V; Brooks JB; Daikos GL
    J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(1):143-51. PubMed ID: 11232844
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Approaches to the validation of animal test systems for assay of protective potency of BCG vaccines.
    Smith DW; Harding GE
    J Biol Stand; 1977; 5(2):131-8. PubMed ID: 407231
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relationship of delayed-type hypersensitivity and acquired cellular resistance in experimental airborne tuberculosis.
    Shapiro CD; Harding GE; Smith DW
    J Infect Dis; 1974 Jul; 130(1):8-15. PubMed ID: 4209864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.